This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Walter A. Orenstein, MD; Kenneth J. Bart, MD; Alan R. Hinman, MD; Stephen R. Preblud, MD; Wayne L. Greaves, MD; Sandra W. Doster; Harrison C. Stetler, MD; Barry

JAMA. 1984;251(15):1988-1994.

Abstract
The licensure of rubella vaccines in the United States in 1969 offered the opportunity to prevent the devastating consequences of congenital rubella infection, including miscarriages, therapeutic abortions, and ital rubella syndrome (CRS), with its average lifetime cost of more than $220,000 per case. With the widespread use of vaccine, rubella transmission in the United States has been reduced to record low levels. Epidemics of rubella and CRS, previously reported every six to nine years, have not occurred, and since 1980, following decreases of rubella incidence rates in the postpubertal population, the endemic incidence rates of CRS have also begun to decrease. We have both the opportunity and the obligation to hasten elimination by (1) ensuring that susceptible females of childbearing age are vaccinated, (2) initiating and/or enforcing existing legislation requiring proof of rubella immunity for all children enrolled in schools, (3) intensifying surveillance for both acquired rubella and CRS, and (4) aggressively controlling rubella outbreaks.

{JAMA 1984;251:1988-1994)

Author Affiliations
From the Immunization Division, Center for Services, Centers for Disease Control, Atlanta

Footnotes
Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Assessment of Perinatal Hepatitis B and Rubella Prevention in New Hampshire Delivery Hospitals
Bascom et al.
Pediatrics 2005;115:e594-e599.
ABSTRACT | FULL TEXT  

Descriptive Epidemiology of Infantile Cataracts in Metropolitan Atlanta, Ga, 1968-1998
Bhatti et al.
Arch Pediatr Adolesc Med 2003;157:341-347.
ABSTRACT | FULL TEXT  

A Large Rubella Outbreak With Spread From the Workplace to the Community
Danovaro-Holliday et al.
JAMA 2000;284:2733-2739.
ABSTRACT | FULL TEXT  

Rubella Outbreak--Westchester County, New York, 1997-1998
Arch Dermatol 1999;135:1284-1285.
FULL TEXT  

Resurgence of Congenital Rubella Syndrome in the 1990s: Report on Missed Opportunities and Failed Prevention Policies Among Women of Childbearing Age
Lee et al.
JAMA 1992;267:2616-2620.
ABSTRACT  

A Profile of Mothers Giving Birth to Infants With Congenital Rubella Syndrome: An Assessment of Risk Factors
Kaplan et al.
Arch Pediatr Adolesc Med 1990;144:118-123.
ABSTRACT  

Rubella and Congenital Rubella Syndrome--United States, 1985-1988
Arch Pediatr Adolesc Med 1989;143:893-894.
ABSTRACT  

Rubella and Congenital Rubella Syndrome-- United States, 1985-1988
Arch Dermatol 1989;125:608-609.
ABSTRACT  

Rubella and Congenital Rubella Syndrome-- United States, 1985-1988
JAMA 1989;261:2179-2180.
 

Immunization Policies and Vaccine Coverage Among Adults: The Risk for Missed Opportunities
WILLIAMS et al.
ANN INTERN MED 1988;108:616-625.
ABSTRACT  

Rubella and Congenital Rubella-- United States, 1984-1986
JAMA 1987;258:2491-2500.
 

Leads from the MMWR
JAMA 1986;255:2265-2270.
 

Eliminating Rubella From the United States
Kindrachuk
JAMA 1986;255:197-197.
ABSTRACT  

Leads from the MMWR
JAMA 1985;254:2387-2388.
 

Some Current Issues Relating to Rubella Vaccine
Preblud
JAMA 1985;254:253-256.
ABSTRACT  

Leads from the MMWR
JAMA 1984;252:1995-1996.
 

Rubella Prevention: Recommendation of the Immunization Practices Advisory Committee
ANN INTERN MED 1984;101:505-513.
ABSTRACT  

Leads from the MMWR
JAMA 1984;251:2774-2779.
 

Birth and Death of Congenital Rubella Syndrome
Plotkin
JAMA 1984;251:2003-2004.
ABSTRACT